Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study.
Saved in:
| Title: | Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study. |
|---|---|
| Authors: | Onishi A; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. telonishi@gmail.com., Tanaka M; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Fujii T; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Murata K; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Murakami K; Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hashimoto M; Department of Clinical Immunology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan., Watanabe R; Department of Clinical Immunology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan., Nozaki Y; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan., Ashida C; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan., Yamamoto W; Department of Health Information Management, Kurashiki Sweet Hospital, Okayama, Japan., Yamada H; Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan., Sendo S; Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan., Ebina K; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.; Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, Osaka, Japan., Makino H; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan., Son Y; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan., Wada Y; Department of Internal Medicine (IV), Osaka Medical and Pharmaceutical University, Osaka, Japan., Hata K; Department of Internal Medicine (IV), Osaka Medical and Pharmaceutical University, Osaka, Japan., Matsuda S; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Morinobu A; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan. |
| Source: | Arthritis research & therapy [Arthritis Res Ther] 2025 Mar 07; Vol. 27 (1), pp. 52. Date of Electronic Publication: 2025 Mar 07. |
| Publication Type: | Journal Article; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40055759 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Onishi+A%22">Onishi A</searchLink>; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. telonishi@gmail.com.<br /><searchLink fieldCode="AU" term="%22Tanaka+M%22">Tanaka M</searchLink>; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.<br /><searchLink fieldCode="AU" term="%22Fujii+T%22">Fujii T</searchLink>; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Murata+K%22">Murata K</searchLink>; Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Murakami+K%22">Murakami K</searchLink>; Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Hashimoto+M%22">Hashimoto M</searchLink>; Department of Clinical Immunology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Watanabe+R%22">Watanabe R</searchLink>; Department of Clinical Immunology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nozaki+Y%22">Nozaki Y</searchLink>; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ashida+C%22">Ashida C</searchLink>; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+W%22">Yamamoto W</searchLink>; Department of Health Information Management, Kurashiki Sweet Hospital, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Yamada+H%22">Yamada H</searchLink>; Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Sendo+S%22">Sendo S</searchLink>; Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Ebina+K%22">Ebina K</searchLink>; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.; Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Makino+H%22">Makino H</searchLink>; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Son+Y%22">Son Y</searchLink>; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Wada+Y%22">Wada Y</searchLink>; Department of Internal Medicine (IV), Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hata+K%22">Hata K</searchLink>; Department of Internal Medicine (IV), Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Matsuda+S%22">Matsuda S</searchLink>; Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Morinobu+A%22">Morinobu A</searchLink>; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101154438%22">Arthritis research & therapy</searchLink> [Arthritis Res Ther] 2025 Mar 07; Vol. 27 (1), pp. 52. <i>Date of Electronic Publication: </i>2025 Mar 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101154438 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1478-6362 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214786354%22">14786354 </searchLink><i>NLM ISO Abbreviation: </i>Arthritis Res Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40055759 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13075-025-03514-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 52 Titles: – TitleFull: Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Onishi A – PersonEntity: Name: NameFull: Tanaka M – PersonEntity: Name: NameFull: Fujii T – PersonEntity: Name: NameFull: Murata K – PersonEntity: Name: NameFull: Murakami K – PersonEntity: Name: NameFull: Hashimoto M – PersonEntity: Name: NameFull: Watanabe R – PersonEntity: Name: NameFull: Nozaki Y – PersonEntity: Name: NameFull: Ashida C – PersonEntity: Name: NameFull: Yamamoto W – PersonEntity: Name: NameFull: Yamada H – PersonEntity: Name: NameFull: Sendo S – PersonEntity: Name: NameFull: Ebina K – PersonEntity: Name: NameFull: Makino H – PersonEntity: Name: NameFull: Son Y – PersonEntity: Name: NameFull: Wada Y – PersonEntity: Name: NameFull: Hata K – PersonEntity: Name: NameFull: Matsuda S – PersonEntity: Name: NameFull: Morinobu A IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 03 Text: 2025 Mar 07 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1478-6362 Numbering: – Type: volume Value: 27 – Type: issue Value: 1 Titles: – TitleFull: Arthritis research & therapy Type: main |
| ResultId | 1 |
